Irbevex 150/Irbevex 300

Irbevex 150/Irbevex 300

irbesartan

Manufacturer:

Vexxa Lifesciences

Distributor:

VE Pharma
Concise Prescribing Info
Contents
Irbesartan
Indications/Uses
Treatment of essential HTN & renal disease in adult patients w/ HTN & type 2 DM as part of an antihypertensive drug regimen.
Dosage/Direction for Use
Initial & maintenance dose: 150 mg once daily. May be increased to 300 mg or other antihypertensive agents can be added. Elderly >75 yr & hemodialysis patient Consider initiating w/ 75 mg. Hypertensive type 2 diabetic patient Initially 150 mg once daily. Maintenance: 300 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Co-administration w/ aliskiren-containing drugs in patients w/ diabetes or w/ moderate to severe renal impairment (GFR <60 mL/min/1.73 m2). Pregnancy (2nd & 3rd trimester).
Special Precautions
Correct intravascular vol- or Na-depletion prior to administration. Increased risk of severe hypotension in patients w/ bilateral renal artery stenosis. Periodic monitoring of K & serum creatinine in patients w/ renal impairment. Monitoring of serum K in patients, suffering from heart failure. Patients w/ recent kidney transplantation, primary aldosteronism, aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy, ischemic cardiopathy or ischemic CV disease. Patients w/ rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption. Lactation. Childn.
Adverse Reactions
Hyperkalemia; dizziness, orthostatic dizziness & HTN, nausea/vomiting, musculoskeletal pain, fatigue.
Drug Interactions
Increased hypotensive effect w/ other hypotensive agents. May increase serum K w/ K-sparing diuretics, K supplements/salt substitutes. Reversible increases in serum lithium conc & toxicity. Reduced antihypertensive effect w/ NSAIDs ie selective cyclooxygenase-2 inhibitors, aspirin >3 g/day.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09CA04 - irbesartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Irbevex 150 tab 150 mg
Packing/Price
30's
Form
Irbevex 300 tab 300 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in